334 related articles for article (PubMed ID: 26970662)
21. Triptolide attenuated injury via inhibiting oxidative stress in Amyloid-Beta25-35-treated differentiated PC12 cells.
Xu P; Wang H; Li Z; Yang Z
Life Sci; 2016 Jan; 145():19-26. PubMed ID: 26679104
[TBL] [Abstract][Full Text] [Related]
22. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity.
Chonpathompikunlert P; Han J; Toh K; Isoda H; Nagasaki Y
Eur J Pharmacol; 2011 Jan; 650(2-3):544-9. PubMed ID: 20969847
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of β-amyloid-induced neurotoxicity by planar analogues of procyanidin B3.
Mizuno M; Mori K; Misawa T; Takaki T; Demizu Y; Shibanuma M; Fukuhara K
Bioorg Med Chem Lett; 2019 Sep; 29(18):2659-2663. PubMed ID: 31371134
[TBL] [Abstract][Full Text] [Related]
24. Melatonin and synthetic analogs as antioxidants.
Suzen S
Curr Drug Deliv; 2013 Feb; 10(1):71-5. PubMed ID: 22998047
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, and the antioxidant, neuroprotective and P-glycoprotein induction activity of 4-arylquinoline-2-carboxylates.
Bharate JB; Wani A; Sharma S; Reja SI; Kumar M; Vishwakarma RA; Kumar A; Bharate SB
Org Biomol Chem; 2014 Aug; 12(32):6267-77. PubMed ID: 25007760
[TBL] [Abstract][Full Text] [Related]
26. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
27. The anti-oxidant effects of melatonin derivatives on human gingival fibroblasts.
Phiphatwatcharaded C; Puthongking P; Chaiyarit P; Johns NP; Sakolchai S; Mahakunakorn P
Arch Oral Biol; 2017 Jul; 79():55-61. PubMed ID: 28292674
[TBL] [Abstract][Full Text] [Related]
28. Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation.
Pagoni A; Marinelli L; Di Stefano A; Ciulla M; Turkez H; Mardinoglu A; Vassiliou S; Cacciatore I
Eur J Med Chem; 2020 Jan; 186():111880. PubMed ID: 31753513
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Yuan W; Liu Q; Shi Y; Ang W; Luo Y; Tan Z; Deng Y
Eur J Med Chem; 2015 Apr; 94():348-66. PubMed ID: 25778991
[TBL] [Abstract][Full Text] [Related]
30. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells.
Zhang L; Yu H; Zhao X; Lin X; Tan C; Cao G; Wang Z
Neurochem Int; 2010 Nov; 57(5):547-55. PubMed ID: 20615444
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer's disease.
Zhou LC; Liang YF; Huang Y; Yang GX; Zheng LL; Sun JM; Li Y; Zhu FL; Qian HW; Wang R; Ma L
Eur J Med Chem; 2021 Jul; 219():113426. PubMed ID: 33848787
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of new indole-2-carboxamide and 3-acetamide derivatives and evaluation their antioxidant properties.
Ölgen S; Bakar F; Aydin S; Nebioğlu D; Nebioğlu S
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):58-64. PubMed ID: 22145595
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08).
Marsh DT; Das S; Ridell J; Smid SD
Bioorg Med Chem; 2017 Jul; 25(14):3827-3834. PubMed ID: 28559058
[TBL] [Abstract][Full Text] [Related]
35. Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells.
Hur J; Pak SC; Koo BS; Jeon S
Pharm Biol; 2013 Jan; 51(1):30-5. PubMed ID: 23134284
[TBL] [Abstract][Full Text] [Related]
36. Effect of sesaminol glucosides on beta-amyloid-induced PC12 cell death through antioxidant mechanisms.
Lee SY; Ha TY; Son DJ; Kim SR; Hong JT
Neurosci Res; 2005 Aug; 52(4):330-41. PubMed ID: 15885833
[TBL] [Abstract][Full Text] [Related]
37. [Novel agonists of melatonin receptors as promising hypotensive and neuroprotective agents for therapy of glaucoma].
Chesnokova NB; Beznos OV; Lozinskaya NA; Volkova MS; Zaryanova EV; Zefirov NA; Grigoryev AV
Biomed Khim; 2017 Jan; 63(1):75-80. PubMed ID: 28251954
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.
Spadoni G; Diamantini G; Bedini A; Tarzia G; Vacondio F; Silva C; Rivara M; Mor M; Plazzi PV; Zusso M; Franceschini D; Giusti P
J Pineal Res; 2006 Apr; 40(3):259-69. PubMed ID: 16499563
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective and Antioxidant Activities of 4-Methylcoumarins: Development of Structure-Activity Relationships.
Malhotra S; Tavakkoli M; Edraki N; Miri R; Sharma SK; Prasad AK; Saso L; Len C; Parmar VS; Firuzi O
Biol Pharm Bull; 2016; 39(9):1544-8. PubMed ID: 27582333
[TBL] [Abstract][Full Text] [Related]
40. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.
Pappolla MA; Chyan YJ; Poeggeler B; Frangione B; Wilson G; Ghiso J; Reiter RJ
J Neural Transm (Vienna); 2000; 107(2):203-31. PubMed ID: 10847561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
